This inventor holds 1 USPTO granted patent. Top assignees: Cns Biotek Corp., Gansu Evergreen Pharmaceuticals, Co., Ltd., Peking University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 667 
Years Active: 2025
Title: Qing Chang: Innovator in Pharmaceutical Composition Against SARS-CoV-2
Introduction
Qing Chang is a notable inventor based in Lanzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against COVID-19. His innovative work focuses on the use of a specific compound, Ovatodiolide, which has shown promise in inhibiting the SARS-CoV-2 virus.
Latest Patents
Qing Chang holds a patent for the "Use of Ovatodiolide against SARS-CoV-2." This patent describes a pharmaceutical composition that includes a safe and effective amount of Ovatodiolide or its pharmaceutically acceptable salts. The composition is designed to treat COVID-19, demonstrating great potential in combating the virus.
Career Highlights
Throughout his career, Qing Chang has worked with prestigious institutions such as Peking University and Cns Biotek Corp. His research and development efforts have been pivotal in advancing pharmaceutical solutions for viral infections.
Collaborations
Qing Chang has collaborated with esteemed colleagues, including Zhen Yang and Yew-Min Tzeng. Their combined expertise has contributed to the successful development of innovative pharmaceutical compositions.
Conclusion
Qing Chang's work exemplifies the vital role of inventors in addressing global health challenges. His patent on Ovatodiolide highlights the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile